血清25-羟基维生素D水平与非酒精性脂肪性肝病患者肝脏纤维化风险的关系(3)
[7] Roth CL， Elfers CT， Figlewicz DP， Melhorn SJ， Morton GJ， Hoofnagle A， Yeh MM， Nelson JE， Kowdley KV. Vitamin D deficiency in obese rats exacerbates nonalcoholic fatty liver disease and increases hepatic resistin and Toll-like receptor activation. Hepatology， 2012， 55(4)：1103-1111.
[8] Abramovitch S， Dahan-Bachar L， Sharvit E， Weisman Y， Ben Tov A， Brazowski E， Reif S. Vitamin D inhibits proliferation and profibrotic marker expression in hepatic stellate cells and decreases thioacetamide-induced liver fibrosis in rats. Gut， 2011， 60(12)：1728-1737.
[9] Barchetta I， Angelico F， Del Ben M， Baroni MG， Pozzilli P， Morini S， Cavallo MG. Strong association between non alcoholic fatty liver disease (NAFLD) and low 25(OH) vitamin D levels in an adult population with normal serum liver enzymes. BMC Med， 2011，9：85.
[10] Black LJ， Jacoby P， She Ping-Delfos WC， Mori TA， Beilin LJ， Olynyk JK， Ayonrinde OT， Huang RC， Holt PG， Hart PH， Oddy WH， Adams LA. Low serum 25-hydroxyvitamin D concentrations associate with non-alcoholic fatty liver disease in adolescents independent of adiposity. J Gastroenterol Hepatol， 2014， 29(6)：1215-1222.
[11] Manco M， Ciampalini P， Nobili V. Low levels of 25-hydroxyvitamin D(3) in children with biopsy-proven nonalcoholic fatty liver disease. Hepatology， 2010， 51(6) ： 2229- 2230.
[12] Dasarathy J， Periyalwar P， Allampati S， Bhinder V， Hawkins C， Brandt P， Khiyami A， McCullough AJ， Dasarathy S. Hypovitaminosis D is associated with increased whole body fat mass and greater severity of non-alcoholic fatty liver disease. Liver Int， 2014， 34(6) ： e118-e127.
[13] Lorvand Amiri H， Agah S， Tolouei Azar J， Hosseini S， Shidfar F， Mousavi SN. Effect of daily calcitriol supplementation with and without calcium on disease regression in non-alcoholic fatty liver patients following an energy-restricted diet： randomized， controlled， double-blind trial. Clin Nutr， 2017， 36(6) ： 1490-1497.
[14] Della Corte C， Carpino G， De Vito R， De Stefanis C， Alisi A， Cianfarani S， Overi D， Mosca A， Stronati L， Cucchiara S， Raponi M， Gaudio E， Byrne CD， Nobili V. Docosahexanoic acid plus vitamin d treatment improves features of NAFLD in children with serum vitamin D deficiency： results from a single centre trial. PLoS One，2016， 11(12) ： e0168216.
(收稿日期： 2018-08-10)
(本文編辑： 杨江瑜), http://www.100md.com(余超?陈利?蔺红梅?姜雨薇?汪丽清?林妙霞)
[8] Abramovitch S， Dahan-Bachar L， Sharvit E， Weisman Y， Ben Tov A， Brazowski E， Reif S. Vitamin D inhibits proliferation and profibrotic marker expression in hepatic stellate cells and decreases thioacetamide-induced liver fibrosis in rats. Gut， 2011， 60(12)：1728-1737.
[9] Barchetta I， Angelico F， Del Ben M， Baroni MG， Pozzilli P， Morini S， Cavallo MG. Strong association between non alcoholic fatty liver disease (NAFLD) and low 25(OH) vitamin D levels in an adult population with normal serum liver enzymes. BMC Med， 2011，9：85.
[10] Black LJ， Jacoby P， She Ping-Delfos WC， Mori TA， Beilin LJ， Olynyk JK， Ayonrinde OT， Huang RC， Holt PG， Hart PH， Oddy WH， Adams LA. Low serum 25-hydroxyvitamin D concentrations associate with non-alcoholic fatty liver disease in adolescents independent of adiposity. J Gastroenterol Hepatol， 2014， 29(6)：1215-1222.
[11] Manco M， Ciampalini P， Nobili V. Low levels of 25-hydroxyvitamin D(3) in children with biopsy-proven nonalcoholic fatty liver disease. Hepatology， 2010， 51(6) ： 2229- 2230.
[12] Dasarathy J， Periyalwar P， Allampati S， Bhinder V， Hawkins C， Brandt P， Khiyami A， McCullough AJ， Dasarathy S. Hypovitaminosis D is associated with increased whole body fat mass and greater severity of non-alcoholic fatty liver disease. Liver Int， 2014， 34(6) ： e118-e127.
[13] Lorvand Amiri H， Agah S， Tolouei Azar J， Hosseini S， Shidfar F， Mousavi SN. Effect of daily calcitriol supplementation with and without calcium on disease regression in non-alcoholic fatty liver patients following an energy-restricted diet： randomized， controlled， double-blind trial. Clin Nutr， 2017， 36(6) ： 1490-1497.
[14] Della Corte C， Carpino G， De Vito R， De Stefanis C， Alisi A， Cianfarani S， Overi D， Mosca A， Stronati L， Cucchiara S， Raponi M， Gaudio E， Byrne CD， Nobili V. Docosahexanoic acid plus vitamin d treatment improves features of NAFLD in children with serum vitamin D deficiency： results from a single centre trial. PLoS One，2016， 11(12) ： e0168216.
(收稿日期： 2018-08-10)
(本文編辑： 杨江瑜), http://www.100md.com(余超?陈利?蔺红梅?姜雨薇?汪丽清?林妙霞)